Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor
Kobayashi, T.; Taniguchi, S.; Ye, Y.; Niekrasz, M.; Kosanke, S.; Neethling, F.A.; Wright, L.J.; Rose, A.G.; White, D.J.; Cooper, D.K.
Transplantation Proceedings 28(2): 560
1996
ISSN/ISBN: 0041-1345 PMID: 8623270 Document Number: 467747
Document emailed within 1 workday
Related Documents
Hancock, W.W.; Blakely, M.L.; Van der Werf, W.; Bach, F.H. 1993: Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation Transplantation Proceedings 25(5): 2932Kemp, E.; Steinbrüchel, D.; Starklint, H.; Larsen, S.; Henriksen, I.; Dieperink, H. 1987: Renal xenograft rejection: prolonging effect of captopril, ACE-inhibitors, prostacyclin, and cobra venom factor Transplantation Proceedings 19(6): 4471-4474
Li, Z-dong.; Shi, C-qing.; Zhang, Q-hua.; Xiong, Y-liang.; Zhou, X-ding.; Wang, W-yu.; Song, N. 2004: Mechanisms of purified cobra venom factor in preventing hyperacute rejection following discordant liver xenotransplantation in rats Zhonghua Yi Xue Za Zhi 84(23): 2007-2010
Lesnikoski, B.A.; Shaffer, D.A.; Van der Werf, W.J.; Dalmasso, A.P.; Soares, M.P.; Latinne, D.; Bazin, H.; Hancock, W.W.; Bach, F.H. 1995: Endothelial and host mononuclear cell activation and cytokine expression during rejection of pig-to-baboon discordant xenografts Transplantation Proceedings 27(1): 290-291
Peng, M.H.; Meng, K.W.; Yang, D.H. 2001: The effect of Chinese cobra venom factor on guinea pig to rat cardiac xenotransplantation Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 15(4): 240-243
Shiau Lin, S.Y.; Su, S.C.; Lee, C.Y. 1976: Comparative studies on cytotoxin from the Indian cobra venom and cardiotoxin from the Formosan cobra venom, with special reference to the effect on the growth of Ehrlich ascites tumor cells in mice Journal of the Formosan Medical Association 75(6): 328-336
Lesnikoski, B.A.; Candinas, D.; Hancock, W.W.; Otsu, I.; Siegel, J.; Bach, F.H.; Robson, S.C. 1996: Inhibition of platelet GPIIbIIIa prolongs survival of discordant cardiac xenografts Transplantation Proceedings 28(2): 703
Pang, A.S.; Minta, J.O. 1980: Inhibition of vitamin D2-induced arteriosclerosis in rats by depletion of complement with cobra venom factor Artery 7(2): 109-122
Hoopes, P.C.; McCall, C.E. 1977: The effect or cobra venom factor (CVJ) activation of the complement cascade on leukocyte circadian variation in the rat Experientia 33(2): 224-226
Fearon, D.T.; Austen, K.F.; Ruddy, S. 1973: Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation Journal of Immunology 111(6): 1730-1736
Martinelli, G.P.; Matsuda, T.; Waks, H.S.; Osler, A.G. 1978: Studies on immunosuppression by cobra venom factor. III. on early responses to sheep erythrocytes in C5-deficient mice Journal of Immunology 121(5): 2052-2055
Cooper, D.K.; Human, P.A.; Reichart, B. 1987: Prolongation of cardiac xenograft (vervet monkey to baboon) function by a combination of total lymphoid irradiation and immunosuppressive drug therapy Transplantation Proceedings 19(6): 4441-4442
Pruitt, S.K.; Baldwin, W.M.; Sanfilippo, F. 1996: The role of C3a and C5a in hyperacute rejection of guinea pig-to-rat cardiac xenografts Transplantation Proceedings 28(2): 596
Tan, N.H.; Arunmozhiarasi, A. 1989: The anticoagulant activity of Malayan cobra (Naja naja sputatrix) venom and venom phospholipase A2 enzymes Biochemistry International 19(4): 803-810
Saxton, N.E.; Hallaway, R.V.; Ladyman, H.M.; Janczynski, B.T.; Nesbitt, A.M.; Zinkewich-Peotti, K.; Smith, R.; Foulkes, R. 1999: Anti-major histocompatibility complex class II treatment prevents graft rejection in the hamster-to-rat cardiac xenograft Transplantation 67(12): 1599-1606
Juhl, H.; Sievers, M.; Baltzer, K.; Helmig, F.; Wolf, H.; Brenner, W.; Kalthoff, H. 1995: A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach Cancer Research 55(23 Suppl): 5749s-5755s
Rosengard, A.M.; Cary, N.; Horsley, J.; Belcher, C.; Langford, G.; Cozzi, E.; Wallwork, J.; White, D.J. 1995: Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts Transplantation Proceedings 27(1): 326-327
Seelig, R.; Seelig, H.P. 1975: The possible role of serum complement system in the formal pathogenesis of acute pancreatitis II. Cobra venom factor pancreatitis--sodiumtaurocholate and deoxycholate pancreatitis Acta Hepato-Gastroenterologica 22(5): 335-346
Lin, Y.; Sobis, H.; Vandeputte, M.; Waer, M. 1995: Natural killer cells, antibody-dependent cellular cytotoxicity, and complement synthesis by the xenograft itself play a role in xenograft rejection Transplantation Proceedings 27(1): 286-287
Borie, D.C.; Cramer, D.V.; Shirwan, H.; Wu, G.D.; Rodriguez, O.; Chapman, F.A.; Makowka, L. 1995: Genetic control of the humoral immune response to xenografts. II. Monoclonal antibodies that cause rejection of heart xenografts are encoded by germline immunoglobulin genes Transplantation 60(12): 1504-1510